Rangeley Capital »

Onkure Therapeutics Inc-a shares owned by Rangeley Capital

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $428k 156k 2.75
2025-06-30 $72k 30k 2.39

More positions owned by Rangeley Capital

Delek Us Holdings (DK)
Calumet (CLMT)
Arvinas Ord (ARVN)
Prothena Corp SHS (PRTA)
Wideopenwest (WOW)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Yext (YEXT)
Keros Therapeutics (KROS)
Arbutus Biopharma (ABUS)
Seaport Entmt Group Common Stock (SEG)
Berto Acquisition Corp Ord Shs (TACO)
Charter Communications Inc N Cl A (CHTR)
Full House Resorts (FLL)
Surgery Partners (SGRY)
Core Scientific *w Exp 01/23/202 (CORZW)

View all positions for Rangeley Capital

Top funds holding Onkure Therapeutics Inc-a

Acorn Capital Advisors
Citadel Advisors
Shay Capital
Vanguard Group
Highbridge Capital Management
Vestal Point Capital
BlackRock
StepStone
Cantor Fitzgerald, L. P.
NEA Management Company
Carlyle
Prosight Management
Renaissance Technologies
Rangeley Capital
Tang Capital Management

View all funds holding Onkure Therapeutics Inc-a